XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.1
SUPPLEMENTAL FINANCIAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of accounts receivable
          
   December 31, 
   2024   2023 
         
Accounts receivable (1)  $18,326   $13,270 
Less: Allowance for doubtful accounts        
Accounts receivable, net  $18,326   $13,270 

 

(1) Accounts receivable denominated in foreign currencies in the years ended 2024 and 2023 represent 11% and 39%, respectively.
Schedule of prepaid and other current assets
               
    December 31,  
    2024     2023  
             
Short term deposits   $ 39,003     $ 50,000  
Deferred offering costs     119,730       100,588  
Prepaid insurance D & O     96,578       34,769  
Prepaid health insurance     16,715        
Prepaid clinical     26,428        
Prepaid annual fees     24,079        
Prepaid insurance other     15,594       17,884  
Prepaid, other     4,167       41,635  
Other receivables           154  
    $ 342,292     $ 245,030  

Schedule of accounts payable
               
    December 31,  
    2024     2023  
             
Accounts payable   $ 525,582     $ 758,821  
Credit cards payable     6,021       1,714  
    $ 531,603     $ 760,535  
Schedule of accrued and other liabilities
          
   December 31, 
   2024   2023 
         
Accrued payroll  $   $162,887 
Accrued bonus   404,228    262,580 
Accrued board compensation   46,250    92,500 
Accrued audit and legal expenses   33,006    89,082 
Investment banking and related fees   15,000    139,906 
Accrued interest       98,685 
Other accrued expenses   30,698    12,082 
   $529,182   $857,722 
Schedule of other expense
               
    Year Ended December 31,  
Income/(Expense)   2024     2023  
             
Bank Interest   $ 318     $ 172  
Taxes     ( )     (1,144 )
Foreign Currency Gain (Loss)     (49     145  
Other           265  
    $ 269     $ (562 )